Lipids and Cardiovascular Risk with CKD

被引：16
作者：
Afshinnia, Farsad [1 ]
Pennathur, Subramaniam [1 ,2 ]
机构：
[1] Univ Michigan, Dept Internal Med Nephrol, 1000 Wall St, Ann Arbor, MI 48105 USA
[2] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA
来源：
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2020年 / 15卷 / 01期
关键词：
chronic kidney disease; cardiovascular disease; lipids; humans; HDL cholesterol; LDL cholesterol; LDL lipoproteins; IDL lipoproteins; metabolic syndrome; chylomicrons; monocytes; cardiovascular diseases; insulin resistance; carrier proteins; cytokines; cholesterol; triglycerides; VLDL lipoproteins; atherosclerosis; dyslipidemias; apolipoproteins; obesity; macrophages; proteinuria; chronic renal insufficiency; DISEASE;
D O I：
10.2215/CJN.13531119
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：5 / 7
页数：3
相关论文
共 50 条
[31]   Lifestyle Strategies for Cardiovascular Risk Reduction [J].
Rippe, James M. ;
Angelopoulos, Theodore J. .
CURRENT ATHEROSCLEROSIS REPORTS, 2014, 16 (10) :1-7
[32]   Lipids and apolipoproteins and the risk of vascular disease and mortality outcomes in women and men with type 2 diabetes in the ADVANCE study [J].
Pikkemaat, Miriam ;
Woodward, Mark ;
Af Geijerstam, Peder ;
Harrap, Stephen ;
Hamet, Pavel ;
Mancia, Giuseppe ;
Marre, Michel ;
Poulter, Neil ;
Chalmers, John ;
Harris, Katie .
DIABETES OBESITY & METABOLISM, 2024, 26 (12) :5669-5680
[33]   Cardiovascular Disease in CKD in Children: Update on Risk Factors, Risk Assessment, and Management [J].
Wilson, Amy C. ;
Mitsnefes, Mark M. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 54 (02) :345-360
[34]   Cardiovascular Risk Factor Burden and Association With CKD in Ghana and Nigeria [J].
Olanrewaju, Timothy O. ;
Osafo, Charlotte ;
Raji, Yemi R. ;
Mamven, Manmak ;
Ajayi, Samuel ;
Ilori, Titilayo O. ;
Arogundade, Fatiu A. ;
Ulasi, Ifeoma I. ;
Gbadegesin, Rasheed ;
Parekh, Rulan S. ;
Tayo, Bamidele ;
Adeyemo, Adebowale A. ;
Adedoyin, Olanrewaju T. ;
Chijioke, Adindu A. ;
Bewaji, Clemen ;
Grobbee, Diederick E. ;
Blankestijin, Peter J. ;
Klipstein-Grobusch, Kerstin ;
Salako, Babatunde L. ;
Adu, Dwomoa ;
Ojo, Akinlolu O. .
KIDNEY INTERNATIONAL REPORTS, 2023, 8 (03) :658-666
[35]   Non-fasting lipids and risk of cardiovascular disease in patients with diabetes mellitus [J].
van Dieren, S. ;
Noethlings, U. ;
van der Schouw, Y. T. ;
Spijkerman, A. M. W. ;
Rutten, G. E. H. M. ;
van der A, D. L. ;
Sluik, D. ;
Weikert, C. ;
Joost, H. G. ;
Boeing, H. ;
Beulens, J. W. J. .
DIABETOLOGIA, 2011, 54 (01) :73-77
[36]   Optimization of time interval for the measurement of plasma lipids for cardiovascular disease risk assessment [J].
Sampson, Maureen ;
Wolska, Anna ;
Zubiran, Rafael ;
Cole, Justine ;
Amar, Marcelo ;
Remaley, Alan T. .
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2024, 24 (1-2) :123-133
[37]   Risk-factor clustering and cardiovascular disease risk in hypertensive patients [J].
Weycker, Derek ;
Nichols, Gregory A. ;
O'Keeffe-Rosetti, Maureen ;
Edelsberg, John ;
Khan, Zeba M. ;
Kaura, Satyin ;
Oster, Gerry .
AMERICAN JOURNAL OF HYPERTENSION, 2007, 20 (06) :599-607
[38]   Waist-to-hip ratio and body mass index as risk factors for cardiovascular events in CKD [J].
Elsayed, Essam F. ;
Tighiouart, Hocine ;
Weiner, Daniel E. ;
Griffith, John ;
Salem, Deeb ;
Levey, Andrew S. ;
Sarnak, Mark J. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 52 (01) :49-57
[39]   Targeting triglycerides to lower residual cardiovascular risk [J].
Bubb, Kristen J. ;
Nelson, Adam J. ;
Nicholls, Stephen J. .
EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2022, 20 (03) :185-191
[40]   Lipids, cardiovascular disease and atherosclerosis in systemic lupus erythematosus [J].
Wierzbicki, AS .
LUPUS, 2000, 9 (03) :194-201
12345